Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin dose comparison in BEP chemotherapy for good-prognosis metastatic non-seminomatous testicular cancer
ISRCTN79658966Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Jan 1986
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of bleomycin, etoposide and cisplatin in testicular cancer, sponsored by Medical Research Council. Primary endpoints: Toxicity and Response. Started Jan 1986; status: completed.
02
Drugs
bleomycinetoposidecisplatin
03
Conditions
testicular cancer
Beyond the preview
Go deeper on ISRCTN79658966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN79658966.